The Depuy Knee lawsuit is a class-action lawsuit that was filed on behalf of those who have suffered pain, inflammation, swelling, and loss of function as a result of an injury to the knee. The defendant is Orthopedics Inc., a medical device manufacturer based in Philadelphia, Pennsylvania. The suit claims that the company’s products promoted by Dr. Steven Teitelbaum were improperly used during thousands of surgeries. This case is being handled by the U.S. Federal Trade Commission, which is charged with the responsibility of regulating interstate and nationwide disputes involving advertising and marketing of products and services.

DePuy Knee lawsuit: DePuy Synthes, Inc. Overview: The FDA has approved the DePuy Attune lower leg prosthesis system , which has been widely utilized in artificial joint replacement at health care facilities throughout the United States.

In that time, however, it has also been implicated in a number of injuries and lawsuits. It was found that although the majority of patients examined were not suffering from any defect, a number of patients who have experienced significant discomfort and pain did so because of the manner in which the device was used. One class in the suit says that the plaintiff’s pain and suffering resulted from the device manufacturer’s misguidance of the intended use of the device.

Depuy Knee Lawsuit: At the time the company recalled its product, DePuy was producing the vast majority of knee replacements.

Those are generally composed of silicone composites that are molded into a metal frame that fits beneath the knee and supports the wearer’s bone. A number of different designs, sizes, materials, and manufacturers are available to choose from for this type of footwear. However, because it is composed of a combination of different materials, it is sometimes hard to know whether or not a particular model is recalled one. It can be hard to track down all of the different parts and components of the product, especially since some manufacturers make the mix up in order to save money.

The company did not take the time to determine whether or not a part of their product was a product recall and did not provide proof that they were aware of the potential dangers of using Depuy Knee.

As a result, the company and its customers are left in potentially risky situations. For instance, if an employee of the company utilizes Depuy knee replacements while they are not supposed to, there is a chance that the body of the wearer could experience damage due to rubbing against metal on the buttocks or legs. Also, if an employee uses the wrong type of knee brace and damages their hip bone, it may be difficult to prove liability unless the manufacturer provides evidence that sigma knee braces or other products are sold with adequate warnings.

It is unclear why the company opted to recall the product in the first place. There is no indication as to why Mr. Merman decided that the Depuy knee braces should be recalled.

His last known comment indicates that he was unaware of the problems that his employees were experiencing but has yet to explain precisely what those problems are.

The manufacturer has also chosen not to offer any sort of financial compensation in the wake of the recall.

Because the recall was caused by shoddy workmanship and because of the potential for serious injury to patients, it is shocking that they would choose to ignore such an issue. There is also the issue of whether or not the company was conscious of the fact that the majority of its patients actually need revision surgery for their condition. Many knee replacement specialists believe that most people actually need a second procedure due to the fact that their first revision surgery was botched. The fact that Mr. Merman’s replacement plan does not offer monetary support is troubling. However, it is also a disappointment that the company has chosen to pursue this case rather than address the situation with the FDA.

Leave a comment

Your email address will not be published. Required fields are marked *